Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Validation of a Prognostic Prediction Model for Adverse Outcomes in Neurocritical Patients Receiving Enteral Nutrition Based on Key Inflammatory and Metabolic Markers

NCT06849011 is registered in ClinicalTrials.gov with Yan Zhang as lead sponsor.

NCT NCT06849011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06849011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Validation of a Prognostic Prediction Model for Adverse Outcomes in Neurocritical Patients Receiving Enteral Nutrition Based on Key Inflammatory and Metabolic Markers
Lead sponsor
Yan Zhang
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
March 31, 2027
Enrollment
1,185 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

encephalitis, non-traumatic brain injury, stroke acute